Diagnostics of Lipids and Lipoproteins

  • H. Wieland
  • W. März
  • M. Nauck


Lipid diagnostics are primarily concerned with the major serum lipids, cholesterol, and triglycerides. Since these molecules are highly hydrophobic, they are transported in the serum in macromolecular complexes of lipids and proteins, called lipoproteins. The principle lipoproteins are low-density lipoprotein (LDL), high-density lipoprotein (HDL), very low density lipoprotein (VLDL), and chylomicrons.


Cholesteryl Ester Cholesteryl Ester Transfer Protein Familial Hypercholesterolemia Familial Hypercholesterolemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aalto-Setälä K, Tikkanen MJ, Taskinen MR, Nieminen M, Holmberg P, Kontula K (1988) XbaI and c/g polymorphism of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 74: 47–54PubMedGoogle Scholar
  2. 2.
    Aalto-Setälä K, Gylling H, Helve E, Kovanen P, Miettinen TA, Turtola H, Kontula K (1989) Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 82: 305–307PubMedGoogle Scholar
  3. 3.
    Alaupovic P, Lee DM, McConathy WJ (1972) Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta 260: 689–707PubMedGoogle Scholar
  4. 4.
    Albers JJ, Hazzard WR (1974) Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids 9: 15–26PubMedGoogle Scholar
  5. 5.
    Albers JJ, Wahl P, Hazzard WR (1974) Quantitative genetic studies of the human plasma Lp(a) lipoprotein. Biochem Genet 11: 475–486PubMedGoogle Scholar
  6. 6a.
    Albers JJ, Adolphson JL, Hazzard WR (1977) Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 18: 331–338PubMedGoogle Scholar
  7. 6b.
    Alcindor LG, Aalam H, Piot MC (1983) Practical value of the selective precipitation of LDL, LDL-phospholipids and the molar ratio of cholesterol to LDL-phospholipids in lecithin-cholesterol-acyltransferase deficiency. Ann Biol Clin 41: 311–314Google Scholar
  8. 7.
    Aqel N, Ball RY, Waldmann H, Mitchinson MJ (1985) Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J Pathol 146: 197–204PubMedGoogle Scholar
  9. 8.
    Armstrong VW, Walli AK, Seidel D (1985) Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 26: 1314–1323PubMedGoogle Scholar
  10. 9.
    Armstrong VW, Seidel D (1985) Evaluation of a commercial kit for the determination of LDL cholesterol in serum based on precipitation of LDL with dextran sulfate. Ärztl Lab 31: 325–330Google Scholar
  11. 10.
    Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D (1986) The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62: 249–257PubMedGoogle Scholar
  12. 11.
    Armstrong VW, Harrach B, Robenek H, Helmhold M, Walli AK, Seidel D (1990) Heterogeneity of human lipoprotein Lp(a): cytochemical and biochemical studies on the interaction of two Lp(a) species with the LDL receptor. J Lipid Res 31: 429–441PubMedGoogle Scholar
  13. 12.
    Assmann G, Jabs HU, Nolte W, Schriewer H (1984) Precipitation of LDL with sulphopolyanions: a comparison of two methods for LDL cholesterol determination. J Clin Chem Clin Biochem 22: 781–785PubMedGoogle Scholar
  14. 13.
    Aubry F, Lapierre YL, Noel C, Davignon J (1971) Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value. Ann Intern Med 75: 231–237PubMedGoogle Scholar
  15. 14.
    Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD (1989) Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 9: 319–325PubMedGoogle Scholar
  16. 15.
    Avogaro PA, Cazzolato G (1975) „Sinking“lipoprotein in normal, hyperlipoproteinaemic and atherosclerotic patients. Clin Chim Acta 61: 239–246Google Scholar
  17. 16.
    Bachorik PS, Wood PD, Albers JJ, Steiner P, Dempsey M, Kuba K, Warnick R, Karlsson L (1976) Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/-manganese precipitation or by ultracentrifugation. Clin Chem 22: 1828–1834PubMedGoogle Scholar
  18. 17.
    Bachorik PS, Cloey TA, Finney CA, Lowry DR, Becker DM (1991) Lipoprotein-cholesterol analysis during screening: accuracy and reliability. Ann Intern Med 114: 741–747PubMedGoogle Scholar
  19. 18.
    Banka CL, Bonnet DJ, Black AS, Smith RS, Curtiss LK (1991) Localization of an apolipoprotein A-I epitope critical for activation of lecithin- cholesterol acyltransferase. J Biol Chem 266: 23886–23892PubMedGoogle Scholar
  20. 19.
    Barrbir M, Wile D, Trayner I, Aber VR, Thompson GR (1988) High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 60: 397–403Google Scholar
  21. 20.
    Barbolini G, Scilabra GA, Botticelli A, Botticelli S (1969) On the origin of foam cells in cholesterol-induced atherosclerosis of the rabbit. Virchows Arch 3: 24–32Google Scholar
  22. 21.
    Bard JM, Delattre-Lestavel S, Clavey V, Pont P, Derudas B, Parra HJ, Fruchart JC (1992) Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E. Biochim Biophys Acta 1127: 124–130Google Scholar
  23. 22.
    Barter PJ, Lally JI (1979) The metabolism of esterified cholesterol in rabbit plasma low density lipoproteins. Biochim Biophys Acta 572: 510–518PubMedGoogle Scholar
  24. 23.
    Barter PJ (1984) HDL metabolism in relation to plasma cholesteryl ester transport. In: Miller NE, Miller GJ (eds) Clinical and metabolic aspects of high density lipoproteins. Elsevier, Amsterdam, p 167–186Google Scholar
  25. 24.
    Bartholomé M, Wieland H, Seidel D (1980) Quantification of plasma lipoprotein cholesterol: a simple procedure for enzymatic determination of cholesterol in electrophoretically separated lipoproteins. Clin Chim Acta 104: 101–105PubMedGoogle Scholar
  26. 25.
    Bartl K, Ziegenhorn J, Steitberger I, Assmann G (1983) Turbidimetric kinetic method for serum low density lipoprotein quantitation. Clin Chim Acta 128: 199–208PubMedGoogle Scholar
  27. 26.
    Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T (1970) Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull WHO 43: 891–915PubMedGoogle Scholar
  28. 27.
    Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341: 162–164PubMedGoogle Scholar
  29. 28.
    Beisiegel U, Weber W, Bengtsson-Olivecrona G (1991) Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 88: 8342–8346PubMedGoogle Scholar
  30. 29.
    Benfante RJ, Reed DM, MacLean CJ, Yano K (1989) Risk factors in middle age that predict early and late onset of coronary heart disease. J Clin Epidemiol 42: 95–104PubMedGoogle Scholar
  31. 30.
    Berg K (1968) Serum lipoproteins. Bibl Haematologica 29: 21–32Google Scholar
  32. 31.
    Berg K, Dahlen G, Frick MH (1974) Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet 6: 230–238PubMedGoogle Scholar
  33. 32.
    Berg K, Dahlen G, Borresen AL (1979) Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin Genet 16: 347–352PubMedGoogle Scholar
  34. 33.
    Berg K (1983) Genetics of coronary heart disease. Prog Med Genet 5: 35–90PubMedGoogle Scholar
  35. 34.
    Berg K (1984) Twin studies of coronary heart disease and its risk factors. Acta Genet Med Gemellol (Roma) 33: 349–361Google Scholar
  36. 35.
    Berg K, Powell LM, Wallis SC, Pease R, Knott TJ, Scott J (1986) Genetic linkage between the antigenic group (Ag) variation and the apolipo-protein B gene: assignment of the Ag locus. Proc Natl Acad Sci USA 83: 7367–7370PubMedGoogle Scholar
  37. 35a.
    Berman M, Hall M, Levy RI, Eisenberg S, Bilheimer DW, Phair RD, Goebel RH (1978) Metabolism of apo B and apo C lipoproteins in man. Kinetic studies in normal and hyperlipoproteinaemic subjects. J Lipid Res 19: 38–56PubMedGoogle Scholar
  38. 36.
    Berg K (1986) DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30: 515–520PubMedGoogle Scholar
  39. 36a.
    Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM (1988) Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 8: 851–857PubMedGoogle Scholar
  40. 37.
    Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch MA, Wallis SC, Powell L, Pease R, Knott TJ, Chu ML, et al. (1986) Structure of the human apolipoprotein B gene. J Biol Chem 261: 15364–15367PubMedGoogle Scholar
  41. 38.
    Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240PubMedGoogle Scholar
  42. 39.
    Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP (1990) Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and non-lipd factors. Circulation 81: 470–476PubMedGoogle Scholar
  43. 40.
    Boerwinkle E, Chan L (1989) A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction. Nucleic Acids Res 17: 4003PubMedGoogle Scholar
  44. 41.
    Bookstein L, Gidding SS, Donovan M, Smith FA (1990) Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. Arch Intern Med 150: 1653–1657PubMedGoogle Scholar
  45. 42.
    Boström K, Lauer SJ, Poksay KS, Garcia Z, Taylor JM, Innerarity TL (1989) Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. J Biol Chem 264: 15701–15708PubMedGoogle Scholar
  46. 43.
    Bouma ME, Pessah M, Renaud G, Amit N, Catala D, Infante R (1988) Synthesis and secretion of lipoproteins by human hepatocytes in culture. In Vitro Cell Dev Biol 24: 85–90PubMedGoogle Scholar
  47. 44.
    Bradley WA, Gianturco SH (1986) Apo E is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary. J Lipid Res 27: 40–48Google Scholar
  48. 45.
    Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298: 1265–1273PubMedGoogle Scholar
  49. 46.
    Breckenridge WC, Maquire GF (1981) Quantification of sinking pre beta lipoprotein in human plasma. Clin-Biochem 14: 82–86PubMedGoogle Scholar
  50. 47.
    Breslow JL (1989) Familial disorders of high density lipoprotein metabolism. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York,p 1253Google Scholar
  51. 48.
    Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT (990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B (see comments). N Engl J Med 323: 1289–1298Google Scholar
  52. 49.
    Brown MS, Goldstein JL (1983) Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 72: 743–747PubMedGoogle Scholar
  53. 50.
    Brown MS, Goldstein JL (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52: 223–261PubMedGoogle Scholar
  54. 51.
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34–47PubMedGoogle Scholar
  55. 52.
    Brown SA, Via DP, Gotto AM Jr, Bradly WA, Gianturco SH (1986) Apolipoprotein E mediated binding of hypertriglyceridemic VLDL to isolated LDL-receptors detected by ligand blotting. Biochem Biophys Res Commun 139: 333–340Google Scholar
  56. 53.
    Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583–595PubMedGoogle Scholar
  57. 54.
    Burstein M, Scholnick HR (1973) Lipoprotein-polyanion-metal interactions. Adv Lipid res 11: 67–108PubMedGoogle Scholar
  58. 55.
    Cambillau M, Simon A, Amar J, Giral P, Atger V, Segond P, Levenson J, Merli I, Megnien JL, Plainfosse MC, et al. (1992) Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA group. Arterioscler Thromb 12: 1346–1352PubMedGoogle Scholar
  59. 56.
    Carlson K, Carlson LA (1975) Comparison of behaviour of very low density lipoproteins of type-III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL lipoprotein. Scand J Clin Lab Invest 35: 655–660PubMedGoogle Scholar
  60. 57.
    Carlson LA, Bottiger LE (1985) Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 218: 207–211PubMedGoogle Scholar
  61. 58.
    Castelli WP, Doyle JT, Gordon T, Harnes CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ (1977) HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55: 767–772PubMedGoogle Scholar
  62. 59.
    Castelli WP (1984) Epidemiology of coronary heart disease: the Framingham study. Am J Med 76: 4–12PubMedGoogle Scholar
  63. 60.
    Castelli WP (1988) Cardiovascular disease in women. Am J Obstet Gynecol 158: 1553–1560PubMedGoogle Scholar
  64. 61.
    Castelli WP (1988) Cholesterol and lipids in the risk of coronary artery disease — the Framingham Heart Study. Can J Cardiol 4, Suppl. A: 5A–10AGoogle Scholar
  65. 62.
    Castelli WP, Wilson PW, Levy D, Anderson K (1989) Cardiovascular risk factors in the elderly. Am J Cardiol 63: 12H–19HPubMedGoogle Scholar
  66. 63.
    Castro GR, Fiedling CJ (1985) Effects of post-prandial lipemia on plasma cholesterol metabolism. J Clin Invest 75: 874–882PubMedGoogle Scholar
  67. 64.
    Cazzolato G, Prakasch G, Green S, Kostner GM (1983) The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chim Acta 135: 203–208PubMedGoogle Scholar
  68. 65.
    Chait A, Brunzell JD, Albers JJ, Hazzard WR (1977) Type-III hyperlipoproteinaemia („remnant removal disease“). Lancet II: 1176–1178Google Scholar
  69. 66.
    Chait A, Hazzard WR, Albers JJ, Kushwaha RP, Brunzell JD (1978) Impaired very low density lipoprotein and triglyceride removal in broad beta disease. Comparison with endogenous hypertrig-lyceridaemia. Metabolism 27: 1055–1066PubMedGoogle Scholar
  70. 67.
    Cham BE (1976) Nature of the interaction between low-density lipoproteins and polyanions and metal ions, as exemplified by heparin and Ca++. Clin Chem 22: 1812–1816PubMedGoogle Scholar
  71. 68.
    Chen SH, Yang CY, Chen PF, Setzer D, Tanimura M, Li WH, Gotto AM Jr, Chan L (1986) The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem 261: 12918–12921PubMedGoogle Scholar
  72. 69.
    Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363–366PubMedGoogle Scholar
  73. 70.
    Cheng Q, Blackett P, Jackson KW, McConathy, WJ, Wang CS (1990) C-terminal domain of apolipoprotein C II as both activator and competitive lipaseinhibitor of lipoprotein lipase. Biochem J 269: 403–407PubMedGoogle Scholar
  74. 71.
    Chesebro B, Svehag SE (1968) Precipitation of human serum proteins by polyethylene glycol. Clin Chim Acta 20: 527–529PubMedGoogle Scholar
  75. 72.
    Cladaras C, Hadzopoulou-Cladaras M, Nolte RT, Atkinson D, Zannis VI (1986) The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. EMBO J 5: 3495–3507PubMedGoogle Scholar
  76. 73.
    Cloey T, Bachorik PS, Becker D, Finney C, Lowry D, Sigmund W (1990) Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA 263: 2788–2789PubMedGoogle Scholar
  77. 74.
    Christian JC, Cheung SW, Kang K, Harmath FP, Huntzinger DJ, Powell RC (1976) Variance of plasma free and esterified cholesterol in adult twins. Am J Hum Genet 28: 174–178PubMedGoogle Scholar
  78. 75.
    Christian JC, Feinleib M, Hulley SB, Castelli WP, Fabsitz RR, Garrison RJ, Borhani NO, Rosenman RH, Wagner J (1976) Genetics of plasma cholesterol and triglycerides: a study of adult male twins. Acta Genet Med Gemellol (Roma) 25: 145–149Google Scholar
  79. 76.
    Connelly PW, Ranganathan S, Maguire GF, Lee M, Myher JJ, Kottke BA, Kuksis A, Little J A (1988) The beta very low density lipoprotein present in hepatic lipase deficiency competitively inhibits low density lipoprotein binding to fibro-blasts and stimulates fibroblast acyl-Co-A cholesterol acyltransferase. J Biol Chem (Canada) 263: 14184–14188Google Scholar
  80. 77.
    Connelly PW, Maguire GF, Lee M, Little J A (1990) Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10: 40–48PubMedGoogle Scholar
  81. 78.
    Cooke PH, Smith SC (1968) Smooth muscle cells: the source of foam cells in atherosclerotic white Carneau pigeons. Exp Mol Pathol 8: 171–189PubMedGoogle Scholar
  82. 79.
    Cremer P, Elster H, Labrot B, Kruse B, Muche R, Seidel D (1988) Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalende Study (GRIPS). Klin Wochenschr 66 [Suppl 11]: 42–49PubMedGoogle Scholar
  83. 80.
    Dahlén G, Ericson C, Furberg C, Lundkvist L, Svardsudd K (1972) Studies on an extra pre-beta lipoprotein fraction. Acta Med Scand [Suppl] 531: 1–29Google Scholar
  84. 81.
    Dahlén G (1974) The pre-beta lipoprotein phe-nomenon in relation to serum cholesterol and triglyceride levels, the Lp(a) lipoprotein and coronary heart disease. Acta Med Scand [Suppl] 570: 1–45Google Scholar
  85. 82.
    Dahlén G, Berg K, Gillnas T, Ericson C (1975) Lp(a) lipoprotein/pre-beta1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease. Clin Genet 7: 334–341PubMedGoogle Scholar
  86. 83.
    Dahlén G, Frick MH, Berg K, Valle M, Wiljasalo M (1975) Further studies of Lp(a) lipoprotein/ pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet 8: 183–189PubMedGoogle Scholar
  87. 84.
    Dahlén G, Berg K, Frick MH (1976) Lp(a) lipoprotein/pre-betal-lipoprotein, serum lipids and atherosclerotic disease. Clin Genet 9: 558–566PubMedGoogle Scholar
  88. 85.
    Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr (1986) Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758–765PubMedGoogle Scholar
  89. 86.
    Davies MS, Wallis SC, Driscoll DM, Wynne JK, Williams GW, Powell LM, Scott J (1989) Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells. J Biol Chem 264: 13395–13398PubMedGoogle Scholar
  90. 87.
    Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1–21Google Scholar
  91. 88.
    Deckelbaum RJ, Eisenberg S, Oschry Y, Granot E, Sharon I, Bengtsson-Olivecrona G (1986) Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases. J Biol Chem 261: 5201–5208PubMedGoogle Scholar
  92. 89.
    Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG (1986) Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harbor Symp Quant Biol 51: 403–409PubMedGoogle Scholar
  93. 90.
    de Faire U, Dahlen G, Liljefors I, Lundman T, Theorell T (1981) Pre-beta1-lipoprotein in patients with ischemic heart disease. Genetic determination and relation to early insulin response. Acta Med Scand 209: 65–68PubMedGoogle Scholar
  94. 91.
    Doerr W (1963) Theorie der Perfusion. In: Bergmann W, Doerr W (eds) Zwanglose Abhandlungen aus dem Gebiete der normalen und pathologischen Anatomie. Perfusionstheorie der Arteriosklerose. Thieme, Stuttgart, 91–97Google Scholar
  95. 92.
    Duguid JB (1946) Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Path Bact 58: 207–212PubMedGoogle Scholar
  96. 93.
    Duguid JB (1948) Thrombosis as a factor in the pathogenesis of aortic atherosclerosis. J Path Bact 60: 57–61PubMedGoogle Scholar
  97. 94.
    Drayna DT, Hegele RA, Hass PE, Emi M, Wu LL, Eaton DL, Lawn RM, Williams RR, White RL, Lalouel JM (1988) Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene. Genomics 3: 230–236PubMedGoogle Scholar
  98. 95.
    Driscoll DM, Wynne JK, Wallis SC, Scott J (1989) An in vitro system for the editing of apolipoprotein B mRNA. Cell 58: 519–525PubMedGoogle Scholar
  99. 96.
    Dunning AM, Houlston R, Frostegard J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S (1991) Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor. Biochim Biophys Acta 1096: 231–237PubMedGoogle Scholar
  100. 97.
    Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D (1988) Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1: 1070–1073PubMedGoogle Scholar
  101. 98.
    Duvic CR, Smith G, Sledge WE, Lee LT, Murray MD, Roheim PS, Gallaher WR, Thompson JJ (1985) Identification of a mouse monoclonal antibody, LHLP-1, specific for human Lp(a). J Lipid Res 26: 540–548PubMedGoogle Scholar
  102. 99.
    Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM (1987) Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 84: 3224–3228PubMedGoogle Scholar
  103. 100.
    Ehnholm C, Garoff H, Simons K, Aro H (1971) Purification and quantitation of the human 115. plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta 236: 431–439PubMedGoogle Scholar
  104. 101.
    Ehnholm C, Garoff H, Renkonen O, Simons K (1972) Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 11: 3229PubMedGoogle Scholar
  105. 102.
    Eisenberg S (1980) Plasma lipoproteins interconversion. Ann NY Acad Sci 348: 30–47PubMedGoogle Scholar
  106. 103.
    Eisenberg S (1985) Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters. J Lipid Res 26: 487–494PubMedGoogle Scholar
  107. 104.
    Ericson C, Dahlen G, Berg K (1977) Interaction of isolated Lp(a) lipoprotein with calcium ions and glycosaminoglycans in vitro. Clin Genet 11: 433–440.PubMedGoogle Scholar
  108. 105.
    Eto M, Watanabe K, Chonan N, Ishii K (1988) Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 72: 123–128.PubMedGoogle Scholar
  109. 106.
    Carmena R, Crepaldi G, De Backer G, de Gennes JL, Eisenberg S, Galton D, Gotto AM, Goodwin JF, Greten H, Hanefeld M, Huttunen JK, Jacotot B, Katan MB, Mann JL, Miettionen TA, Norum KR, Oganov RG, Olsson AG, Paoletti R, Pometta D, Pyorala K. Schettler G, Shepherd J, Schwandt P, Tikkanen MJ (1988) The recognition and management of hyperlipidaemia in adults: policy statement of the European Atherosclerosis Society. Eur Heart J 9: 571–600Google Scholar
  110. 107.
    Fagiotto A, Ross R, Harker L (1984) Studies of 123. hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4: 323–340Google Scholar
  111. 108.
    Ferns GA, Robinson D, Galton DJ (1988) DNA 124. haplotypes of the human apoprotein B gene in coronary atherosclerosis. Hum Genet 1988, 81: 76–80Google Scholar
  112. 109.
    Fielding CJ (1984) The origin and properties of 125. free cholesterol potential gradients in plasma, and their relation to atherogenesis. J Lipid Res 25: 1624–1628.PubMedGoogle Scholar
  113. 110.
    Fielding CJ (1987) Factors affecting the rate of catalyzed transfer of cholesteryl esters in plasma. Am Heart J 113: 532–537PubMedGoogle Scholar
  114. 111.
    Fless GM, Scanu AM (1979) Isolation and characterization of the three major low density lipoproteins from normolipidemic rhesus monkeys (Macaca mulatta). J Biol Chem 254: 8653–8661PubMedGoogle Scholar
  115. 112.
    Fless GM, Fischer-Dzoga K, Juhn DJ, Bates S, Scanu AM (1982) Structural and functional 128 changes of rhesus serum low density lipoproteins during cycles of diet-induced hypercholesterolemia. Arteriosclerosis 1982, 2: 475–486Google Scholar
  116. 113.
    Fless GM, ZumMallen ME, Scanu AM (1986) Physiochemical properties of apolipoprotein(a) and lipoprotein(a−) derived from the dissociation of human plasma lipoprotein(a). J Biol Chem 261: 8712–8718PubMedGoogle Scholar
  117. 114.
    Floren CH, Albers JJ, Bierman EL (1981) Uptake of Lp(a) lipoprotein by cultured fibroblasts. Biochem Biophys Res Commun 102 (2): 636–639PubMedGoogle Scholar
  118. 115.
    Fojo SS, de Gennes JL, Beisiegel U (1991) Molecular genetics of apoC-II and lipoprotein lipase deficiency. Adv Exp Med Biol 285: 329–333Google Scholar
  119. 116.
    Fojo SS, Brewer HB (1992) Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 231: 669–677PubMedGoogle Scholar
  120. 117.
    Fong LG, Parthasarathy S, Witztum JL, Steinberg D (1987) Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipd Res 28: 1466–1477Google Scholar
  121. 118.
    Fowler S, Shio H, Haley NJ (1979) Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. Lab Invest 41: 372–378PubMedGoogle Scholar
  122. 119.
    Fowler S (1980) Characterization of foam cells in experimental atherosclerosis. Acta Med Scand [Suppl] 642: 151–158Google Scholar
  123. 120.
    Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 34–42PubMedGoogle Scholar
  124. 121.
    Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 94–103PubMedGoogle Scholar
  125. 122.
    Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 148–156PubMedGoogle Scholar
  126. 123.
    Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 215–225PubMedGoogle Scholar
  127. 124.
    Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 273–281PubMedGoogle Scholar
  128. 125.
    Frick MH, Dahlen G, Berg K, Valle M, Hekali P (1978) Serum lipids in angiographically assessed coronary atherosclerosis. Chest 73: 62–65PubMedGoogle Scholar
  129. 126.
    Friedewald WT, Levy RJ, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18: 499–509PubMedGoogle Scholar
  130. 127.
    Fruchart JC, Ailhaud G (1992) Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem 38: 793–797PubMedGoogle Scholar
  131. 128.
    Gabelli C, Gregg RE, Zech LA, Manzato E, Brewer BH (1986) Abnormal low density metabolism in apolipoprotein E deficiency. J Lipid Res 27: 326–333Google Scholar
  132. 129.
    Gaton E, Wolman M (1977) The role of smooth muscle cells and hematogenous macrophages in atheroma. J Pathol 123: 123–128PubMedGoogle Scholar
  133. 130.
    Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH (1983) Human plasma lipoprotein (a). Structural properties. J Biol Chem 258: 4582–4589PubMedGoogle Scholar
  134. 131.
    Gaubatz JW, Cushing GL, Morrisett JD (1986) Quantitation, isolation, and characterization of human lipoprotein(a). Methods Enzymol 129: 167–186PubMedGoogle Scholar
  135. 132.
    Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD (1990) Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 31: 603–613PubMedGoogle Scholar
  136. 133.
    Gerrity RG, Naito HK, Richardson M, Schwartz CJ (1979) Dietary induced atherogenesis in swine. Am J Pathol 95: 775–793PubMedGoogle Scholar
  137. 134.
    Gerrity RG, Naito HK (1980) Ultrastructural identifications of monocyte-derived foam cells in fatty streak lesions. Artery 8: 208–214PubMedGoogle Scholar
  138. 135.
    Gerrity RG, Naito HK (1980) Lipid clearance from fatty streak lesions by foam cell migration. Artery 8: 215–219PubMedGoogle Scholar
  139. 136.
    Ghilain JM, Parfonry A, Kozyreff V, Heller FR (1988) Lipoprotein(a), cholesterol, and coronary heart diseases. Lancet II: 963Google Scholar
  140. 137.
    Ghiselli G, Schaefer EJ, Gascon P, Breser HB Jr (1981) Type-III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 214: 1239–1241Google Scholar
  141. 138.
    Ghiselli G, Gregg RE, Brewer HB Jr (1984) Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins. Biochim Biophys Acta 794: 333–339Google Scholar
  142. 139.
    Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA (1982) Separation and quantitation of sub-classes of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23: 1206–1223PubMedGoogle Scholar
  143. 140.
    Ginsberg HN, Le NA, Gibson JC (1985) Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. J Clin Invest 75: 614–623PubMedGoogle Scholar
  144. 141.
    Ginsburg BE, Zetterström R (1980) Serum cholesterol concentrations in early infancy. Acta Paediatr Scand 69: 581–585PubMedGoogle Scholar
  145. 142.
    Glomset JA (1968) The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 9: 155–167PubMedGoogle Scholar
  146. 143.
    Glomset JA, Norum KR, Nichols AV, King WC, Mitchell CD, Applegate KR, Gong EL, Glone E (1975) Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest [Suppl] 35: 1–55Google Scholar
  147. 144.
    Goldbourt U, Neufeld HN (1986) Genetic aspects of arteriosclerosis. Arteriosclerosis 6: 357–377PubMedGoogle Scholar
  148. 145.
    Goldstein JL, Brown MS (1973) Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci USA 70: 2804–2808PubMedGoogle Scholar
  149. 146.
    Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 333–377PubMedGoogle Scholar
  150. 147.
    Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley RW (1980) Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J Biol Chem 255: 1839–1848PubMedGoogle Scholar
  151. 148.
    Goldstein JL, Brown MS (1984) Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res 25: 1450–1461PubMedGoogle Scholar
  152. 149.
    Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343: 425–430PubMedGoogle Scholar
  153. 150.
    Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA (1986) High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 74: 1217–1225PubMedGoogle Scholar
  154. 151.
    Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knike JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79: 8–15PubMedGoogle Scholar
  155. 152.
    Gotto AM Jr (1983) High-density lipoproteins: biochemical and metabolic factors. Am J Cardiol 52: 2B–4BPubMedGoogle Scholar
  156. 153.
    Gregg RE, Zech LA, Schaefer EJ, Brewer HB Jr (1981) Type-III hyperlipoproteinemia defective metabolism of an abnormal apolipoprotein E. Science 211: 584–586Google Scholar
  157. 154.
    Gregg RE, Brewer HB Jr (1988) The role of apo-lipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. Clin Chem 34: B28–32Google Scholar
  158. 155.
    Grundy SM, Mok HYI (1976) Chylomicron clearance in normal and hyperlipidemic man. Metabolism 25: 1225–1239PubMedGoogle Scholar
  159. 156.
    Grundy SM, Vega GL, Kesianiemi YA (1985) Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease. Acta Med Scand [Suppl] 701: 23–37Google Scholar
  160. 157.
    Gunby P (1983) High HDL2 levels lower post-prandial lipids [news]. JAMA 249: 1250PubMedGoogle Scholar
  161. 158.
    Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL (1991) Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype. Atherosclerosis 86: 69–83PubMedGoogle Scholar
  162. 159.
    Gutzwiller F, Bertel O, Darioli R, Epstein FH, Hartmann G, Keller U, Kummer H, Mordasini R, Noseda G, Pometta D, Rickenbach M, Riesen W, Rutishauser W, Stähelin HB (1989) Lipide und die Prävention der koronaren Herzkrankheit: Diagnostik und Massnahmen. Schweiz Ärztezeitung 70: 1279–1292Google Scholar
  163. 160.
    Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM Jr (1985) Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis 5: 265–272PubMedGoogle Scholar
  164. 161.
    Gylling H, Aalto-Setälä K, Kontula K, Miettionen TA (1991) Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Arterioscler Thromb 11: 1368–1375Google Scholar
  165. 162.
    Hagman M, Wilhelmsen L, Wedel H, Pennert K (1987) Risk factors for angina pectoris in a population study of Swedish men. J Chronic Dis 40: 265–275PubMedGoogle Scholar
  166. 163.
    Haley NJ, Shio H, Fowler S (1977) Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. I. Resolution of aortic cell populations by metrizamide density gradient centrifugation. Lab Invest 37: 287–296PubMedGoogle Scholar
  167. 164.
    Hamilton RL, Williams MC, Fielding CJ, Havel RJ (1976) Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 58: 667–683PubMedGoogle Scholar
  168. 165.
    Hamsten A, Wallidus G, Dahlen G, Johansson B, de Faire U (1986) Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 59: 223–235Google Scholar
  169. 166.
    Hamsten A, Iselius L, Dahlen G, De Faire U (1986) Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. Atherosclerosis 60: 199–208PubMedGoogle Scholar
  170. 167.
    Harvie NR, Schultz JS (1973) Studies on the heterogeneity of human serum Lp lipoproteins and on the occurrence of double Lp lipoprotein variants. Biochem Genet 9: 235–245PubMedGoogle Scholar
  171. 168.
    Hatch FT (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1–68PubMedGoogle Scholar
  172. 169.
    Haust MD, More RH (1963) Significance of the smooth muscle cell in atherogenesis. In: Jones RJ (ed) Evolution of the atherosclerotic plaque. University of Chicago Press, Chicago, pp 51–63Google Scholar
  173. 170.
    Haust MD (1977) Myogenic foam cells in explants of fatty dots and streaks from rabbit aorta. Morphological studies. Atherosclerosis 26: 441–464PubMedGoogle Scholar
  174. 171.
    Havel RJ, Kane JP, Kashyap ML (1973) Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 52: 32–38PubMedGoogle Scholar
  175. 172.
    Havel RJ (1984) The formation of LDL: mechanisms and regulation. J Lipid Res 25: 1570–1576PubMedGoogle Scholar
  176. 172a.
    Havel RJ (1982) Med Clin North Am 66: 319–333PubMedGoogle Scholar
  177. 173.
    Hazzard WR, Bierman EL (1975) The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type-III). J Lab Clin Med 86: 239–252PubMedGoogle Scholar
  178. 174.
    Hearn JA, Donohue BC, Ba’albaki H, Douglas JS, King SB, Lembo NJ, Roubin GS, Sgoutas DS (1992) Usefulness of serum lipoprotein(a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 69: 736–739PubMedGoogle Scholar
  179. 175.
    Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL (1986) Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315: 1509–1515PubMedGoogle Scholar
  180. 176.
    Henriksen T, Mahoney EM, Steinberg E (1981) Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78: 6499–6503PubMedGoogle Scholar
  181. 177.
    Henriksen T, Mahoney EM, Steinberg D (1982) Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 3: 149–159Google Scholar
  182. 178.
    Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7: 4119–4127PubMedGoogle Scholar
  183. 179.
    Herz J, Kowal RC, Ho YK, Brown MS, Goldstein JL (1990) Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. J Biol Chem 265: 21355–21362PubMedGoogle Scholar
  184. 180.
    Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS (1991) 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 266: 21232–21238Google Scholar
  185. 181.
    Hetland ML, Haarbo J, Christiansen C (1992) One measurement of serum total cholesterol is enough to predict future levels in healthy postmenopausal women. Am J Med 92: 25–28PubMedGoogle Scholar
  186. 182.
    Hinek A, Rosnowski A (1975) Comparison of morphology of isolated cells obtained from aortas of normal and cholesterol fed rabbits. Paroi Arterielle 3: 17–29PubMedGoogle Scholar
  187. 183.
    Hobbs HH, Brown MS, Goldstein JL, Russell DW (1986) Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia. J Biol Chem 261: 13114–13120PubMedGoogle Scholar
  188. 184.
    Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hyperchelesterolemia. Hum Mutat: 445–466Google Scholar
  189. 185.
    Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O’Neil J, Kramer J, Lytle B (1988) Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 77: 1238–1244PubMedGoogle Scholar
  190. 186.
    Hoff HF, O’Neil J, Chisolm GM 3d, Cole TB, Quehenberger O, Esterbauer H, Jurgens G (1989) Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 9: 538–549PubMedGoogle Scholar
  191. 187.
    Hoff HF, O’Neil J, Yashiro A (1993) Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions. J Lipid Res 34: 789–798PubMedGoogle Scholar
  192. 188.
    Holme I, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG (1980) Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study. Am J Epidemiol 112: 149–160PubMedGoogle Scholar
  193. 189.
    Horrigan S, Campbell JH, Campbell GR (1991) Oxidation of beta-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Arteriscler Thromb 11: 279–289Google Scholar
  194. 190.
    Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Benett PH (1984) Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis 4: 462–471.PubMedGoogle Scholar
  195. 191.
    Huff MW, Telford DE (1985) Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig. Metabolism 34: 36–42PubMedGoogle Scholar
  196. 192.
    Huff MW, Telford DE, Woodcroft K, Strong WL (1985) Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs. J Lipid Res 26: 1175–1186.PubMedGoogle Scholar
  197. 193.
    Hui DY, Innerarity TL, Mahley RW (1984) Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type-III hyperlipoproteinemic patients. Importance of a prolipoprotein E. J Biol Chem 259: 860–869Google Scholar
  198. 194.
    Hussain MM, Zannis VI (1990) Intracellular modification of human apolipoprotein AII (apoAII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins. Biochem 29: 209–217Google Scholar
  199. 195.
    Innerarity TL, Friedlander EJ, Rall SC, Weisgraber KH, Mahley RW (1983) The receptor binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem 258: 12341–12347Google Scholar
  200. 196.
    Innerarity TL, Arnold KS, Weisgraber KH, Mahley RW (1986) Apolipoprotein E is the determinant that mediates the receptor uptakes of beta-very low density lipoproteins by mouse macrophages. Arteriosclerosis 6: 114–122Google Scholar
  201. 197.
    Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ (1990) Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31: 1337 - 1349PubMedGoogle Scholar
  202. 198.
    Iselius L, Dahlen G, de Faire U, Lundman T (1981) Complex segregation analysis of the Lp(a)/pre-beta 1-lipoprotein trait. Clin Genet 20: 213. 147–151Google Scholar
  203. 199.
    Iverius PH, Laurent TC (1967) Precipitation of some plasma proteins by the addition of dextran or polyethylene glycol. Biochim Biophys Acta 133: 371–373PubMedGoogle Scholar
  204. 200.
    Jacobs DR Jr, Barrett-Connor E (1982) Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am J Epidemiol 116: 878–885PubMedGoogle Scholar
  205. 201.
    James RW, Martion B, Pometta D, Fruchart JC, Duriez P, Puchois P, Farriaux JP, Tacquet A, Demant T, Clegg RJ (1989) Apolipoprotein B metabolism in homozygous hypercholesterolaemia. J Lipid Res 30: 159–169PubMedGoogle Scholar
  206. 202.
    Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B (1980) Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 10: 161–172PubMedGoogle Scholar
  207. 203.
    Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima I, Yamamura T, Yamamoto A, Tarui S (1984) Increased frequency of lipoprotein disorders similar to type-III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 51: 241–249PubMedGoogle Scholar
  208. 204.
    Kanalas JJ, Makker SP (1991) Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 266: 10825–10829PubMedGoogle Scholar
  209. 205.
    Kannel WB (1980) Influence of blood lipids on risk in hypertension. Hypertension update. In: Hunt JC (ed) Dialogoes in Hypertension. Heart Learning System Inc., Bloomfield, New YorkGoogle Scholar
  210. 206.
    Karädi I, Kostner GM, Gries A, Nimpf J, Romics L, Malle E (1988) Lipoprotein(a) and plasminogen are immunochemically related. Biochim Biophys Acta 960: 91–97PubMedGoogle Scholar
  211. 207.
    Karlin JB, Johnson WJ, Benedict CR, Chacko GK, Phillips MC, Rothblat GH (1987) Cholesterol flux between cells and high density lipoprotein. Lack of relationship to specific binding of the lipoprotein to the cell surface. J Biol Chem 262: 12557–12564PubMedGoogle Scholar
  212. 208.
    Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N (1984) The seven countries study: 2289 deaths in 15 years. Prev Med 13: 141–154PubMedGoogle Scholar
  213. 209.
    Keys A (1988) High density lipoprotein cholesterol and longevity. J Epidemiol Community Health 42: 60–65PubMedGoogle Scholar
  214. 210.
    Kita T, Brown MS, Bilheimer DW, Goldstein JL (1982) Delayed clearence of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc Natl Acad Sci USA 79: 5693–5607PubMedGoogle Scholar
  215. 211.
    Kitamura M (1991) Historical aspects of cholesterol value by various analytical methods. Rinsho Byori 39: 495–500PubMedGoogle Scholar
  216. 212.
    Kjeldsen SE, Eide I, Leren P, Foss OP (1983) Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides. Scand J Clin Lab Invest 43: 119–121PubMedGoogle Scholar
  217. 213.
    Knott TJ, Rail SC Jr, Innerarity TL, Jacobson SF, Urdea MS, Levy-Wilson B, Powell LM, Pease RJ, Eddy R, Nakai H, et al. (1985) Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science 230: 37–43PubMedGoogle Scholar
  218. 214.
    Knott TJ, Pease RJ, Powell LM, Wallis SC, Rail SC Jr, Innerarity TL, Blackhart B, Taylor WH, Marcel Y, Milne R, et al. (1986) Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323: 734–738PubMedGoogle Scholar
  219. 215.
    Koo C, Wernette-Hammond ME, Innerarity TL (1986) Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. J Biol Chem 261: 11194–11201PubMedGoogle Scholar
  220. 216.
    Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, Bilheimer DW, Mahley RW, Innerarity TL (1988) Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoproteins receptors. J Clin Invest 81: 1332–1340PubMedGoogle Scholar
  221. 217.
    Kostner G, Alaupovic P (1972) Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry 11: 3419–3428PubMedGoogle Scholar
  222. 218.
    Kostner GM, Patsch JR, Sailer S, Braunsteiner H, Holasek A (1974) Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur J Biochem 45: 611–621PubMedGoogle Scholar
  223. 219.
    Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB (1981) Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38: 51–61PubMedGoogle Scholar
  224. 220.
    Kostner GM, Molinari E, Pichler P (1985) Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chim Acta 148: 139–147PubMedGoogle Scholar
  225. 221.
    Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM (1990) Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry 29: 640–644.PubMedGoogle Scholar
  226. 222.
    Kowal RC, Herz J, Goldstein JL, Esser V, Brown MS (1989) Low density lipoprotein receptor-related protein mediates uptake of cholesterol esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 86: 5810–5814.PubMedGoogle Scholar
  227. 223.
    Kozarevic D, McGee D, Vojvodic N, Gordon T, Racic Z, Zukel W, Dawber T (1981) Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. Am J Epidemiol 114: 21–28.PubMedGoogle Scholar
  228. 224.
    Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G (1989) Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 83: 137–142PubMedGoogle Scholar
  229. 225.
    Kratzin H, Armstrong VW, Niehaus M, Hilschmann N, Seidel D (1987) Structural relationship of an apolipoprotein(a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler 368: 1533–1544.PubMedGoogle Scholar
  230. 226.
    Krauss RM (1987) Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J 113: 578–582PubMedGoogle Scholar
  231. 227.
    Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Dete KM, Levy RI (1987) Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet II: 62–66Google Scholar
  232. 228.
    Krempler F, Kostner G, Bolzano K, Sandhofer F (1978) Studies on the metabolism of the lipoprotein Lp(a) in man. Atherosclerosis 30: 57–65PubMedGoogle Scholar
  233. 229.
    Krempler F, Kostner G, Bolzano K, Sandhofer F (1979) Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim Biophys Acta 575: 63–70PubMedGoogle Scholar
  234. 230.
    Krempler F (1980) Stoffwechsel und klinische Bedeutung des Lipoproteins Lp(a). Acta Med Austriaca 7: 101–103PubMedGoogle Scholar
  235. 231.
    Krempler F (1980) Metabolism of lipoprotein Lp(a). Artery 8: 151–156PubMedGoogle Scholar
  236. 232.
    Krempler F, Kostner GM, Bolzano K, Sandhofer F (1980) Turnover of lipoprotein(a) in man. J Clin Invest 65: 1483–1490PubMedGoogle Scholar
  237. 233.
    Krempler F, Kostner GM, Roscher A, Haslauer F, Bolzano K, Sandhofer F (1983) Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man. J Clin Invest 71: 1431–1441PubMedGoogle Scholar
  238. 234.
    Krempler F (1984) Untersuchungen über Stoffwechsel und mögliche Mechanismen der Atherogenität von Lipoprotein(a). Wien Klin Wochenschr [Suppl] 151: 1–12Google Scholar
  239. 235.
    Kristensen T, Moestrup SK, Gliemann J, Bendtsen L, Sand O, Sottrup-Jensen L (1990) Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha 2-macroglobulin receptor. FEBS Lett 276: 151–155PubMedGoogle Scholar
  240. 236.
    Kreuzer H, Seidel D (1986) The association between serum Lp(a) concentration and angio-graphically assessed coronary atherosclerosis. Atherosclerosis 62: 249–257PubMedGoogle Scholar
  241. 237.
    Kuprionite JA (1983) Incidence of ischaemic heart disease in relation to blood cholesterol level, and the influence on non-medicamentous preventive measures on the cholesterol level in an open population. Cor Vasa 25: 413–421PubMedGoogle Scholar
  242. 238.
    Kwiterovich PO Jr (1988) HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem 34: B71–77PubMedGoogle Scholar
  243. 239.
    Labeur C, Michiels G, Bury J, Usher DC, Rosseneu M (1989) Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with mono-clonal antibodies. Clin Chem 35: 1380–1384PubMedGoogle Scholar
  244. 240.
    Ladias JA, Kwiterovich PO Jr, Smith HH, Miller M, Bachorik PS, Forte T, Lusis AJ, Antonarakis SE (1989) Apolipoprotein B-100 Hopkins (arginine 4019 — tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia. JAMA 262: 1980–1988PubMedGoogle Scholar
  245. 241.
    Lalazar A, Weisgraber KH, Rall SC Jr, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley RW, et al. (1988) Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem 263: 3542–3545Google Scholar
  246. 242.
    Lamm G, Csukas M, Gyarfas J, Ostor E (1985) Risk factors for coronary heart disease in rural Hungary. Int J Epidemiol 14: 327–329PubMedGoogle Scholar
  247. 243.
    Landis BA, Rotolo FS, Meyers WC, Clark AB, Quarfordt SH (1987) Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am J Physiol 252: 805–810Google Scholar
  248. 244.
    Laplaud PM, Beaubatie L, Rall SC Jr, Luc G, Saboureau M (1988) Lipoprotein(a) is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J Lipid Res 29: 1157–1170PubMedGoogle Scholar
  249. 245.
    Lapidus L (1985) Ischaemic heart disease, stroke and total mortality in women — results from a prospective population study in Gotheburg, Sweden. Acta Med Scand 705 [Suppl] 14K: 1–42Google Scholar
  250. 246.
    Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG, Miller GJ, et al. (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet I: 1301–1303Google Scholar
  251. 247.
    Law SW, Grant SM, Higuchi K, Hospattankar A, Lackner K, Lee N, Brewer HB Jr (1986) Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc Natl Acad Sci USA 83: 8142–8146PubMedGoogle Scholar
  252. 248.
    Lawn R (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132–137Google Scholar
  253. 249.
    Leary T (1941) The genesis of atherosclerosis. Arch Path 32: 507–555Google Scholar
  254. 250.
    Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB, Cornoni-Huntley JC (1987) Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 40: 775–784PubMedGoogle Scholar
  255. 251.
    Lees RS, Fredrickson DS (1965) The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis. J Clin Invest 44: 1968–1977PubMedGoogle Scholar
  256. 252.
    Lewis B (1983) Relation of high-density lipoproteins to coronary artery disease. Am J Cardiol 52: 5B–8BPubMedGoogle Scholar
  257. 253.
    Leszczynski DE, Cleveland JC, Kummerow FA (1980) Plasma lipoprotein patterns in patients hospitalized for coronary artery bypass surgery. Clin Cardiol 3: 252–259PubMedGoogle Scholar
  258. 254.
    Linden L, Kallberg M, Gustafson A, Dahlen G (1976) Studies on an additional pre-beta-lipoprotein, sinking pre-beta (SPB). I. Isolation and characterization. Scand J Clin Lab Invest 36: 51–58PubMedGoogle Scholar
  259. 255.
    Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship fo reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365–374Google Scholar
  260. 256.
    Lipinska I, Gurewich V, Meriam CM, Kosowsky BD, Ramaswamy K, Philibin E, Losordo D (1987) Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease. Artery 15: 44–60PubMedGoogle Scholar
  261. 257.
    Logan RL, Riemersma RA, Oliver MF, Olsson AG, Rossner S, Wallidus G, Kaijser L, Carlson LA, Locherbie L, Lutz W, The Edinburgh-Stockholm-Study of coronary heart disease risk factors: a summary. In: Kritchevcky D, Paoletti R, Holmes WL (eds) Drugs, lipid metabolism and atherosclerosis. Plemun, New York, pp 287–294Google Scholar
  262. 258.
    Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23: 882–884PubMedGoogle Scholar
  263. 259.
    Mabuchi H, Itoh H, Takeda M, Kajinami K, Wakasugi T, Koizumi J, Takeda R, Asagami C (1989) A young type-III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism 38: 115–119Google Scholar
  264. 260.
    Maeda H, Nakamura H, Kobori S, Okada M, Niki H, Ogura T, Hiraga S (1989) Molecular cloning of a human apolipoprotein E variant: E5 (Glu3-Lys3). J Biochem (Tokyo) 105: 491–493Google Scholar
  265. 261.
    Maeda H, Nakamura H, Kobori S, Okada M, Mori H, Niki H, Ogura T, Hiraga S (1989) Identification of human apolipoprotein E variant gene: apolipoprotein E7 (Glu244,245-Lys244,245). J Biochem (Tokyo) 105: 51–54Google Scholar
  266. 262.
    März W, Ruzicka C, Pohl T, Usadel KH, Gross W (1992) Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient [letter]. Lancet II, 340: 1362Google Scholar
  267. 263.
    Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL (1980) Cholesterol ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J Pipid Res 21: 970–980Google Scholar
  268. 264.
    Mahley RW, Hui DY, Innerarity TL, Weisgraber KH (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B, E and apo-E receptors. J Clin Invest 68: 1197–1206Google Scholar
  269. 265.
    Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622–630PubMedGoogle Scholar
  270. 266.
    Mahley RW, Hui DY, Innerarity TL, Beisiegel U (1989) Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake. Atherosclerosis 9: 114–18Google Scholar
  271. 267.
    Mailly F, Xu CF, Xhignesse M, Lussier-Cacan S, Talmud PJ, Davignon J, Humphries SE, Nestruck AC (1991) Characterization of a new aolipoprotein E5 variant detected in two French-Canadian subjects. J Lipid Res 32: 613–620PubMedGoogle Scholar
  272. 268.
    Mann WA, Gregg RE, Sprecher DL, Brewer HB Jr (1989) Apolipoprotein E-lHarrisburg: a new variant of apolipoprotein E dominantly associated with type-III hyperlipoproteinemia. Biochim Biophys Acta 1005: 239–244Google Scholar
  273. 269.
    Marth E, Cazzolato G, Bittolo Bon G, Avogaro P, Kostner GM (1982) Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers. Ann Nutr Metab 26: 56–62PubMedGoogle Scholar
  274. 270.
    Masket BH, Levy RI, Fredrickson DS (1973) The use of Polyacrylamide gel electrophoresis in differentiating type 3 hyperlipoproteinemia. J Lab Clin Med 81: 794–802PubMedGoogle Scholar
  275. 271.
    McLean JW, Elshourbagy NA, Chang DJ, 282. Mahley RW, Taylor JM (1984) Human apolipoprotein E mRNA, cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem 259: 6498–6504Google Scholar
  276. 272.
    McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132–137Google Scholar
  277. 273.
    McQueen MJ, Henderson AR, Patten RL, Krishnan S, Wood DE, Webb S (1991) Results of a province-wide quality assurance program assessing the accuracy of cholesterol, triglycerides, and high-density lipoprotein cholesterol measurements and calculated low-density lipoprotein cholesterol in Ontario, using fresh human serum. Arch Pathol Lab Med 115: 1217–1222PubMedGoogle Scholar
  278. 274.
    Mendez AJ, Oram JF, Bierman EL (1991) Role of the protein kinase C signaling pathway in high-density lipoprotein receptor-mediated efflux of intracellular cholesterol. Trans Assoc Am Physicians 104: 48–53PubMedGoogle Scholar
  279. 275.
    Mendez AJ, Oram JF, Bierman EL (1991) Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266: 10104–10111PubMedGoogle Scholar
  280. 276.
    Meng QH, Calabresi L, Fruchart JC, Marcel YL (1993) Apolipoprotein A-I domains involved in the activation of lecithin: cholesterol acyltransferase. Importance of the central domain. J Biol Chem 268: 16966–16973.PubMedGoogle Scholar
  281. 277.
    Menotti A, Seccareccia F (1987) Blood pressure, serum cholesterol and smoking habits predicting different manifestations of arteriosclerotic cardiovascular diseases. Acta Cardiol 42: 91–102.PubMedGoogle Scholar
  282. 278.
    Menzinger P, Sitzmann FC (1979) Vergleich zweier Cholesterinbestimmungsmethoden bei Kindern (Liebermann-Burchard und vollenzymatischer Farbtest). Klin Padiatr 191: 61–65PubMedGoogle Scholar
  283. 278a.
    Miettinen TA, Gylling H (1988) Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients. Arteriosclerosis 8: 163–167.PubMedGoogle Scholar
  284. 279.
    Metherall JE, Goldstein JL, Luskey KL, Brown MS (1989) Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells. J Biol Chem 264: 15634–15641PubMedGoogle Scholar
  285. 279a.
    Miller NE, Hammett F, Saltissi S, Rao S, van Zeller H, Coltart J, Lewis B (1981) Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipo- proteins. Br Med J 282: 1741–1744.Google Scholar
  286. 280.
    Moberly JB, Cole TG, Alpers DH, Schonfeld G (1990) Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochem Biophys Acta 1042: 70–80.PubMedGoogle Scholar
  287. 281.
    Molgaard J, Klausen IC, Lassvik C, Faergeman O, Gerdes LU, Olsson AG (1992) Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication. Arterioscler Thromb 12: 895–901PubMedGoogle Scholar
  288. 282.
    Moestrup SK, Gliemann J (1991) Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. J Biol Chem 266: 14011–14017PubMedGoogle Scholar
  289. 283.
    Moestrup SK, Gliemann J, Pallesen G (1992) Distribution of the alpha 2-macroglobulin receptor/ low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269: 375–382PubMedGoogle Scholar
  290. 284.
    Moll PP, Powsner R, Sing CF (1979) Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. V. Variance components estimated from pedigrees. Ann Hum Genet 42: 343–354PubMedGoogle Scholar
  291. 285.
    Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM, Humphries SE (1988) DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis 70: 123–129PubMedGoogle Scholar
  292. 286.
    Morton NE, Gulbrandsen CL, Rhoads GG, Kagan A (1978) The Lp lipoprotein in Japanese. Clin Genet 14: 207–212PubMedGoogle Scholar
  293. 287.
    Myant NB (1990) Current approaches to the genetics of coronary heart disease (CHD) including an account of work done at Hammersmith Hospital. Boll Soc Ital Biol Sper 66: 1015–1041PubMedGoogle Scholar
  294. 288.
    Nakaya N, Chung BH, Patsch JR, Taunton OD (1977) Synthesis and release of low density lipoproteins by the isolated perfused pig liver. J Biol Chem 252: 7530–7533PubMedGoogle Scholar
  295. 289.
    National Cholesterol Education Program (1994) Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 89: 1330–1445Google Scholar
  296. 290.
    Nestel PJ, Fifge NH, Tan MH (1982) Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307: 329–333PubMedGoogle Scholar
  297. 291.
    Neubeck W, Wieland H, Habenicht A, Muller P, Baggio G, Seidel D (1977) Improved assessment of plasma lipoprotein patterns. III. Direct measurement of lipoproteins after gel-electrophoresis. Clin Chem 23: 1296–1300PubMedGoogle Scholar
  298. 292.
    Nichols AV, Gong EL, Blanche PJ, Forte TM, Shore VG (1987) Pathways in the formation of human plasma high density lipoprotein subpopulations containing apolipoprotein A-I without apolipoprotein A-II. J Lipid Res 28: 719–732PubMedGoogle Scholar
  299. 293.
    Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ (1980) Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61: 503–508PubMedGoogle Scholar
  300. 294.
    Oram JF, Brinton EA, Bierman EL (1983) Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J Clin Invest 72: 1611–1621PubMedGoogle Scholar
  301. 295.
    Oram JF, Johnson CJ, Brown TA (1987) Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages: evidence for reversible binding at the cell surface without internalization. J Biol Chem 262: 2405–2410PubMedGoogle Scholar
  302. 296.
    Orlando RA, Kerjaschki D, Kurihara H, Biemesderfer D, Farguhar MG (1992) gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc Natl Acad Sci USA 89: 6698–6802Google Scholar
  303. 298.
    Osborne TF (1991) Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 266: 13947–13951PubMedGoogle Scholar
  304. 299.
    Oschry Y, Olivecrona T, Deckelbaum RJ, Eisenberg S (1985) Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein? J Lipid Res 26: 158–167.PubMedGoogle Scholar
  305. 300.
    Ose L, Kalager T, Grundt IK (1976) Serum beta-lipoprotein subfractions in Polyacrylamide gel electrophoresis associated with coronary heart disease. Scand J Clin Lab Invest 36: 75–79PubMedGoogle Scholar
  306. 301.
    Pachauri SP, Jacotot B, Beaumont JL (1976) Circulating lipophages and aortic foam cells in experimental atherosclerosis of rabbits under altered reticuloendothelial activity. Nutr Metab 20: 14–26.PubMedGoogle Scholar
  307. 302.
    Packard CJ, Clegg RJ, Dominiczak MH, Lorimer AR, Shepherd J (1986) Effects of bezafibrate on apolipoprotein B metabolism in type-III hyperlipoproteinaemic subjects. J Lipid Res 27: 930–938PubMedGoogle Scholar
  308. 303.
    Pagnan A, Donadon W, Tonolli E (1974) Corona- ropatia e banda pre-beta „accessorial“: una relazione causale? Minerva Med 65: 3123–3126PubMedGoogle Scholar
  309. 304.
    Pagnan A, Kostner G, Braggion M, Ziron L, Bittolo-Bon G, Avogaro P (1983) Familial study 317. on „sinking pre-beta“, the Lp(a) lipoprotein, and its relationship with serum lipids, apolipoprotein A-I and B and clinical atherosclerosis. J Clin Chem Clin Biochem 21: 267–272.PubMedGoogle Scholar
  310. 305.
    Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM (1985) Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 82: 3445–3449.Google Scholar
  311. 306.
    Palac RT, Meadows WR, Hwang MH, Loeb HS, Pifarre R, Gunnar RM (1982) Risk factors related to progressive narrowing in aortocoronary vein grafts studies 1 and 5 years after surgery. Circulation 66: 140–144.Google Scholar
  312. 307.
    Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86: 1372–1376PubMedGoogle Scholar
  313. 308.
    Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325–335.PubMedGoogle Scholar
  314. 309.
    Papadopoulos NM, Bedynek JL (1973) Serum lipoprotein patterns in patients with coronary atherosclerosis. Clin Chim Acta 44: 153–157PubMedGoogle Scholar
  315. 310.
    Parthasarathy S, Steinbrecher UP, Barnett J, Witztum JL, Steinberg D (1985) Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82: 3000–3004PubMedGoogle Scholar
  316. 311.
    Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D (1986) Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arterioslerosis 6: 505–510Google Scholar
  317. 312.
    Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D (1989) Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis 9: 398–404PubMedGoogle Scholar
  318. 313.
    Patsch JR, Sailer S, Kostner G, Sandhofer F, Holasek A, Braunsteiner H (1974) Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res 15: 356–366PubMedGoogle Scholar
  319. 314.
    Patsch JR (1975) Lipoprotein of the density 1.006–1.020 in the plasma of patients with type-III hyperlipoproteinaemia in the postabsorptive state. Eur J Clin Invest 5: 45–55PubMedGoogle Scholar
  320. 315.
    Patsch JR, Prasad S, Gotto AM Jr, Bengtsson-Olivecrona G (1984) Postprandial lipemia: a key for the conversion of HDL2 into HDL3 by hepatic lipase. J Clin Invest 74: 2017–2023PubMedGoogle Scholar
  321. 316.
    Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen MJ (1989) Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the seven countries study. Br Med J 299: 81–85Google Scholar
  322. 317.
    Persson B, Johansson BW (1984) The Kockum study: twenty-two-year follow-up. Coronary heart disease in a population in the south of Sweden. Acta Med Scand 216: 485–493PubMedGoogle Scholar
  323. 318.
    Pfaffinger D, Schuelke J, Kim C, Fless GM, Scanu AM (1991) Relationship between apo(a) isoforms and Lp(a) density in subjects with different apo(a) phenotype: a study before and after a fatty meal. J Lipid Res 32: 679–683PubMedGoogle Scholar
  324. 319.
    Poison A, Potgieter GM, Largier JF, Mears GEF, Joubert FJ (1964) The fractionation of protein mixtures by linear polymers of high molecular weight. Biochim Biophys Acta 82: 463–475Google Scholar
  325. 320.
    Postle AD, Darmady JM, Siggers DC (1978) Double pre-beta lipoprotein in ischaemic heart disease. Clin Genet 13: 233–236PubMedGoogle Scholar
  326. 321.
    Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J (1987) A novel form of tissue- specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50: 831–840PubMedGoogle Scholar
  327. 322.
    Prokhorskas RP, Grabauskas VI, Baubinene AV, Glazunov IS, Domarkene SB (1987) Chief risk factors of ischemic heart disease and mortality of the middle-aged male population of Kaunas. Kardiologiia 27: 14–19PubMedGoogle Scholar
  328. 323.
    Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC (1987) Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 68: 35–40PubMedGoogle Scholar
  329. 324.
    Quarfordt S, Levy RI, Fredrickson DS (1971) On the lipoprotein abnormality in type 3 hyperlipoproteinemia. J Clin Invest 50: 754–761PubMedGoogle Scholar
  330. 325.
    Ragland DR, Brand RJ (1988) Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidemiol 127: 462–475PubMedGoogle Scholar
  331. 326.
    Rajput-Williams J, Knott TJ, Wallis SC, Sweetnam P, Yarnell J, Cox N, Bell GI, Miller NE, Scott J (1988) Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet II: 1442–1446Google Scholar
  332. 327.
    Rail SC Jr, Weisgraber KH, Mahley RW (1982) Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257: 4171–4178Google Scholar
  333. 328.
    Rail SC Jr, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP (1989) Type-III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J Clin Invest 83: 1095–1101Google Scholar
  334. 329.
    Rath M, Pauling L (1990) Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc Natl Acad Sci USA 87: 9388–9390PubMedGoogle Scholar
  335. 330.
    Raychowdhury R, Niles JL, McCluskey RT, Smith JA (1989) Autoimmune target Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244: 1163–1165PubMedGoogle Scholar
  336. 331.
    Reardon MF, Poapst ME, Steiner G (1982) The independent synthesis of intermediate density lipoproteins in type-III hyperlipoproteinaemia. Metabolism 31: 421–427PubMedGoogle Scholar
  337. 332.
    Reardon MF, Nestel PJ, Craig IH, Harper RW (1985) Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71: 881–888PubMedGoogle Scholar
  338. 333.
    Rodgrave TG (1970) Formation of cholesteryl esterrich particulate lipid during metabolism of chylomicrons. J Clin Invest 49: 465–471Google Scholar
  339. 334.
    Rhoads GG, Morton NE, Gulbrandsen CL, Kagan A (1978) Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii. Am J Epidemiol 108: 350–356PubMedGoogle Scholar
  340. 335.
    Rhoads GG, Dahlén G, Berg K, Morton NE, Dannenberg AL (1986) Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256: 2540–2544PubMedGoogle Scholar
  341. 336.
    Rittner C, Wichmann D (1967) Zur Genetik des Lp-Systems. Nachweis der erblichen quantitativen Merkmalsprägung sowie einer pränatalen Selektion. Humangenetik 5 (1): 43–53Google Scholar
  342. 337.
    Rivin AU (1989) Total and high-density lipoprotein cholesterol measurements. Hazards in clinical interpretation. West J Med 15: 289–291Google Scholar
  343. 338.
    Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL (1991) Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 87: 90–99PubMedGoogle Scholar
  344. 339.
    Rothblat GH, Bamberger M, Phillips MC (1986) Reverse cholesterol transport. In: Albers JJ, Segrest JP (eds) Methods in enzymology, vol 129. Academic, London, pp 628–644Google Scholar
  345. 340.
    Rubba P, Faccenda F, Iorio D, Pauciullo P, Cortese C, Spampinato N, Mancini M (1987) Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease. Int Angiol 6: 331–337PubMedGoogle Scholar
  346. 341.
    Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G (1985) Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Götheborg, Sweden. J Hypertens 3: 167–176PubMedGoogle Scholar
  347. 342.
    Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G (1990) Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 36: 20–23PubMedGoogle Scholar
  348. 343.
    Sato R, Imanaka T, Takano T (1990) The effect of HMG-CoA reductase inhibitor (cs-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2. Biochim Biophys Acta 1042: 36–41PubMedGoogle Scholar
  349. 344.
    Saxena U, Goldberg IJ (1990) Interaction of li-poprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim Biophys Acta 1043 (2): 161–168PubMedGoogle Scholar
  350. 345.
    Scanu AM (1990) Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med 116: 142–146PubMedGoogle Scholar
  351. 346.
    Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer HB JR (1986) Familial apolipoprotein E deficiency. J Clin Invest 78: 1206–1219Google Scholar
  352. 347.
    Schaefer EJ, McNamara JR, Genest J Jr, Ordovas JM (1988) Clinical significance of hypertriglyceridemia. Semin Thromb Hemost 14: 143–148PubMedGoogle Scholar
  353. 348.
    Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, Glagov S, Wissler RW (1980) Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 100: 57–80PubMedGoogle Scholar
  354. 349.
    Schauer UJ, Pissarek D, Panzram G (1989) Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study. Acta Diabetol 26: 35–42Google Scholar
  355. 350.
    Schneider WJ, Koyanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley RW (1981) Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibro-blasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68: 1075–1085Google Scholar
  356. 351.
    Schultz JS, Shreffler DC, Harvie NR (1968) Genetic and antigenic studies and partial purification of a human serum lipoprotein carrying the Lp antigenic determinant. Proc Natl Acad Sci USA 61: 963–970PubMedGoogle Scholar
  357. 352.
    Schultz JS, Schreffler DC, Sing CF, Harvie NR (1974) The genetics of the Lp antigen. I. Its quantitation and distribution in a sample population. Ann Hum Genet 38: 39–46PubMedGoogle Scholar
  358. 353.
    Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, Utermann G (1990) Relation of serum lipoprotein(a) concen-tration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 322: 1494–1499PubMedGoogle Scholar
  359. 354.
    Schmitz G, Robenek H, Lohmann U, Assmann G (1985) Interaction of high density lipoproteins with cholesterylester laden macrophages: biochemical and morpholigical characterization of cell surface binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J 4: 613–622PubMedGoogle Scholar
  360. 355.
    Schulte H, Assmann G (1988) Results of the „Munster Prospective Cardiovascular“study. Soz Präventivmed 33: 337–345Google Scholar
  361. 356.
    Scott DW, Gotto AM, Cole JS, Gorry GA (1978) Plasma lipids as collateral risk factors in coronary artery disease — a study of 371 males with chest pain. J Chronic Dis 34: 337–345Google Scholar
  362. 357.
    Sheperd J, Packard CJ (1987) Metabolic heterogeneity in very low density lipoproteins. Am Heart J 113: 503–507Google Scholar
  363. 358.
    Sherrill BC, Innerarity TL, Mahley RW (1980) Rapid hepatic clearance of the canine lipoproteins containing only the E-apoprotein by high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem 255: 1804–1807PubMedGoogle Scholar
  364. 359.
    Sigurdsson G, Nicoll A, Lewis B (1976) The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia. Eur J Clin Invest 6: 151–158PubMedGoogle Scholar
  365. 360.
    Simons K, Ehnholm C, Renkonen O, Bloth B (1970) Characterization of the Lp(a) lipoprotein in human plasma. Acta Pathol Microbiol Immunol Scand [B] 78: 459–466Google Scholar
  366. 361.
    Simons LA (1986) Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 57: 5G–10GPubMedGoogle Scholar
  367. 362.
    Simons LA, Dwyer T, Simons J, Bernstein L, Mack P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J (1987) Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Artherosclerosis 65: 181–189Google Scholar
  368. 363.
    Sing CF, Orr JD (1978) Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. IV. Separation of polygene from common environment effects. Am J Hum Genet 30: 491–504PubMedGoogle Scholar
  369. 364.
    Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr (1980) Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins). Proc Natl Acad Sci USA 77: 604–608PubMedGoogle Scholar
  370. 365.
    Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO Jr (1982) Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med 97: 833–839PubMedGoogle Scholar
  371. 366.
    Sniderman A, Cianflone K, Kwiterovich PO Jr, Hutchinson T, Barre P, Prichard S (1987) Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Atherosclerosis 65: 257–264PubMedGoogle Scholar
  372. 367.
    Solakivi T, Salo MK, Puska P, Nikkari T (1988) Plasma apolipoprotein B in middle-aged Finnish men. Evidence for a regional gradient of apo B and lack of negative correlation between apo B and dietary linoleate in hyperapobetalipoproteinemia. Atherosclerosis 72: 55–61PubMedGoogle Scholar
  373. 368.
    Solberg LA, Strong JP, Holme I, Helgeland A, Hjermann I, Leren P, Mogensen SB (1985) Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study. Lab Invest 53: 648–655PubMedGoogle Scholar
  374. 369.
    Solberg LA, Ishii T, Strong JP, Guzman MA, Hosoda Y, Tsugane S, Newman WP, Tracy RE (1987) Comparison of coronary atherosclerosis in middle-aged Norwegian and Japanese men. An autopsy study. Lab Invest 56: 451–456PubMedGoogle Scholar
  375. 370.
    Soutar AK, Garner CW, Baker HN, Sparrow JT, Jackson RL, Gotto AM, Smith LC (1975) Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry 14: 3057–3064PubMedGoogle Scholar
  376. 371.
    Soutar AK, Myant NB, Thompson GR (1977) Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis 28: 247–256PubMedGoogle Scholar
  377. 372.
    Soutar AK, Myant NB, Thompson GR (1982) The metabolism of very-low-density and intermediate-density lipoproteins in patients with familial hypercholesterolaemia. Atherosclerosis 43: 217–231PubMedGoogle Scholar
  378. 373.
    Spady DK, Turley SD, Dietschy JM (1985) Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences. J Clin Invest 76: 1113–1122PubMedGoogle Scholar
  379. 374.
    Sporik R, Johnstone JH, Cogswell JJ (1991) Longitudinal study of cholesterol values in 68 children from birth to 11 years of age. Arch Dis Child 66: 134–137PubMedGoogle Scholar
  380. 375.
    Sprecher DL, Hoeg JM, Schaefer EJ, Zech LA, Gregg RE, Lakatos E, Brewer HB Jr (1985) The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism 34: 294–299PubMedGoogle Scholar
  381. 376.
    Stamler J, Wentworth D, Neaton JD (1986) Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial. Am J Med 80: 33–39PubMedGoogle Scholar
  382. 377.
    Stamler J, Wentworth D, Neaton JD (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple risk Factor Intervention Trial (MRFIT). JAMA 256: 2823–2828PubMedGoogle Scholar
  383. 378.
    Stary HC (1980) The intimal macrophage in atherosclerosis. Artery 8: 205–207PubMedGoogle Scholar
  384. 379.
    Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81: 3883–3887PubMedGoogle Scholar
  385. 380.
    Steinbrecher UP, Lougheed M, Kwan WC, Dirks M (1989) Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem 264: 15216–15223PubMedGoogle Scholar
  386. 381.
    Steiner G, Schwartz L, Shumak S, Poapst M (1987) The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75: 124–130PubMedGoogle Scholar
  387. 382.
    Steinmetz A, Jakobs C, Motzny S. Kaffarnik H (1989) Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis 9: 405–411PubMedGoogle Scholar
  388. 383.
    Stewart JM, Packard CJ, Lorimer AR, Boag DE, Shepherd J (1982) Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects. Atherosclerosis 44: 355–365PubMedGoogle Scholar
  389. 384.
    Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorini M, Argraves WS (1990) Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265: 17401–17404PubMedGoogle Scholar
  390. 385.
    Stuhldreher WL, Orchard TJ, Donahue RP, Kuller LH, Gloninger MF, Drash AL (1991) Cholesterol screening in childhood; sixteen-year Beaver County Lipid Study. J Pediatr 119: 551–556PubMedGoogle Scholar
  391. 386.
    Suckling KE, Stange EF (1985) Role of acylCoA: cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 26: 647–671PubMedGoogle Scholar
  392. 387.
    Südhof TC, Goldstein JL, Brown MS, Russell DW (1985) The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228: 815–822PubMedGoogle Scholar
  393. 388.
    Swift LL, Manowitz NR, Dunn GD, Lequire VS (1980) Isolation and characterization of hepatic Golgi lipoproteins from hypercholesterolemic rats. J Clin Invest 66: 415–425PubMedGoogle Scholar
  394. 389.
    Takebayashi S, Kubota I, Kamio A, Takagi T (1972) Ultrastructural aspects of human atherosclerosis; role of the foam cells and modified smooth muscle cells. J Electron Microsc (Tokyo) 21: 301–313Google Scholar
  395. 390.
    Tatami R, Mabuchi H, Ueda K, Ueda B, Haba T, KametaniT, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R (1981) Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64: 1174–1184Google Scholar
  396. 391.
    Tajima S, Yamamura T, Yamamot A (1988) Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. J Biochem (Tokyo) 104: 48–52Google Scholar
  397. 392.
    Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89: 9252–9256PubMedGoogle Scholar
  398. 393.
    Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR, et al. (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis 67: 81–89PubMedGoogle Scholar
  399. 394.
    Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr (1983) Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci USA 80: 6662–6666PubMedGoogle Scholar
  400. 395.
    Teng B, Sniderman AD, Soutar AK, Thompson GR (1986) Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 77: 663–672PubMedGoogle Scholar
  401. 396.
    Teramoto T, Matsushima T, Horie Y, Watanabe T (1990) Production of apolipoprotein E-rich LDL by the liver. The effect of dietary cholesterol and some lipid lowering agents. Ann NY Acad Sci 598: 301–307PubMedGoogle Scholar
  402. 397.
    Theeret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, Ailhaud G (1990) Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem Biophys Res Commun 173: 1361–1368Google Scholar
  403. 398.
    Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M (1989) Genotypic and phenotypic variation in familial hypercholesterolemia. Arteriosclerosis 9: 175–80Google Scholar
  404. 399.
    Thuren T, Weisgraber KH, Sisson P. Waite M (1992) Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 31: 2332–2338PubMedGoogle Scholar
  405. 400.
    Tikkanen M, Schonfeld G (1985) The reconition domain for the low density lipoproteins cellular receptor is expressed only once on each lipoprotein particle. Biochem Biophys Res Commun 126: 773–777PubMedGoogle Scholar
  406. 401.
    Tikkanen MJ, Viikari J, Akerblom HK, Pesonen E (1988) Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentrations in Finnis children. Br Med J [Clin Res] 296: 169–170Google Scholar
  407. 402.
    Tornberg SA, Jakobsson KF, Eklund GA (1988) Stability and validity of a single serum cholesterol measurement in a prospective cohort study. Int J Epidemiol 17: 797–803PubMedGoogle Scholar
  408. 403.
    Tverdal A, Foss OP, Lern P, Holme I, Lund-Larsen PG, Bjartveit K (1989) Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol 129: 458–465PubMedGoogle Scholar
  409. 404.
    Tybjaerg-Hansen A, Humphries SE (1992) Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis 96: 91–107.PubMedGoogle Scholar
  410. 405.
    Utermann G, Wiegandt H (1971) Comparative studies of the Lp(a)-lipoprotein and low density lipoproteins of human serum. Hoppe Seylers Z Physiol Chem 352: 938–946.PubMedGoogle Scholar
  411. 406.
    Utermann G, Lipp K, Wiegandt H (1972) Studies on the Lp(a)-lipoprotein of human serum. IV. The disaggregation of the Lp(a)-lipoprotein. Humangenetik 14: 142–150PubMedGoogle Scholar
  412. 407.
    Utermann G, Hees M, Steinmetz A (1977) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269: 604–607Google Scholar
  413. 408.
    Utermann G, Canzler H, Hees M, Jaeschke M, Muhlfeiler G, Schoenborn W, Vogelberg KH (1977) Studies on the metabolic defect in Broadbeta disease (hyperlipoproteinaemia type-III). Clin Genet 12 (3): 139–154PubMedGoogle Scholar
  414. 409.
    Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H (1979) Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type-III. Clin Genet 15: 37–62Google Scholar
  415. 410.
    Utermann G, Pruin N, Steinmetz A (1979) Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 15: 63–72.Google Scholar
  416. 411.
    Utermann G (1987) Apolipoprotein E polymorphism in health and disease. Am Heart J 113: 433–440Google Scholar
  417. 412.
    Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentration in plasma. J Clin Invest 80: 458–465PubMedGoogle Scholar
  418. 413.
    Utermann G, Kraft HG, Menzel HJ, Hopferwieser T, Seitz C (1988) Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 78: 41–46PubMedGoogle Scholar
  419. 414.
    Utermann G, Duba C, Menzel HJ (1988) Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 78: 47–50PubMedGoogle Scholar
  420. 415.
    Utermann G (1989) The mysteries of lipoprotein(a). Science 246: 904–910.PubMedGoogle Scholar
  421. 416.
    van Lenten BJ, Fogelman AM, Hokom MM, Benson L, Haberland ME, Edwards PA (1983) Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J Biol Chem 258: 5151–5157PubMedGoogle Scholar
  422. 417.
    Viikari J (1976) Precipitation of plasma lipoproteins by PED-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 36: 265–268.Google Scholar
  423. 418.
    Virchow R (1852) Über parenchymatöse Entzündung. Virchows Arch Path Anat 4: 261–324Google Scholar
  424. 419.
    Virchow R (1859) Die Bindegewebsfrage. Virchows Arch Path Anat 16: 2–20Google Scholar
  425. 420.
    Virchow R (ed) (1867) Krankheiten der Blutund Lymphgefäße, von Lebert, Erlangen, pp 335–353 (Handbuch der speciellen Pathologie und Therapie, vol V, 2 )Google Scholar
  426. 421.
    Vu-Dac N, Chekkor A, Parra H, Duthilleul P, Fruchart JC (1985) Latex immunoassay of human serum Lp(a+) lipoprotein. J Lipid Res 26: 267–269PubMedGoogle Scholar
  427. 422.
    Vu-Dac N, Mezdour H, Parra HJ, Luc G, Luyeye I, Fruchart JC (1989) A selective bi-site immunoenzymatic procedure for human Lp(a) lipoprotein quantification using monoclonal antibodies against apo(a) and apoB. J Lipid Res 30: 1437–1443PubMedGoogle Scholar
  428. 423.
    Walton KW, Hitchens J, Magnani HN, Khan M (1974) A study of methods of identification and estimation of Lp(a) lipoprotein and its significance in health, hyperlipidaemia and atherosclerosis. Atherosclerosis 20: 323–346PubMedGoogle Scholar
  429. 424.
    Walton KW (1975) Factors affecting lipoprotein deposition in the arterial wall. In: Hautvast JG, et al. (eds) Blood and arterial wall in atherogenesis and arterial thrombosis. Brill, Leiden, pp 79–86Google Scholar
  430. 425.
    Wardell MR, Brennan SO, Janus ED, Fräser R, Carrell RW (1987) Apolipoprotein E2-Christchurch (136 Arg-Ser). New variant of human apolipoprotein E in a patient with type-III hyperlipoproteinemia. J Clin Invest 80: 483–490Google Scholar
  431. 426.
    Wardell MR, Weisgraber KH, Havekes LM, Rail SC Jr (1989) Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127. J Biol Chem 264: 21205–21210PubMedGoogle Scholar
  432. 427.
    Wardell MR, Rail SC Jr, Schaefer EJ, Kane JP, Weisgraber KH (1991) Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J Lipid Res 32: 521–528PubMedGoogle Scholar
  433. 428.
    Wasenius A, Stugaard M, Otterstad JE, Froyshov D (1990) Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest 50: 635–642PubMedGoogle Scholar
  434. 429.
    Weinstock N, Bartholome M, Seidel D (1981) Determination of apolipoprotein A-I by kinetic nephelometry. Biochim Biophys Acta 663: 279–288PubMedGoogle Scholar
  435. 430.
    Weisgraber KH, Mahley RW (1978) Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253: 6281–6288PubMedGoogle Scholar
  436. 431.
    Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteinearginine interchange at a single site. J Biol Chem 257: 2518–2521Google Scholar
  437. 432.
    Weisgraber KH, Rail SC Jr, Innerarity TL, Mahley RW, Kuusi T, Ehnholm C (1984) A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. J Clin Invest 73: 1024–1033Google Scholar
  438. 433.
    Weisgraber KH, Shinto LH (1991) Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem 266: 12029–12034PubMedGoogle Scholar
  439. 434.
    Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E (1981) Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis 39: 411–424PubMedGoogle Scholar
  440. 435.
    Wiegandt H, Lipp K, Wendt GG (1968) Identifizierung eines Lipoproteins mit Antigenwirksamkeit im Lp-System. Hoppe Seylers Z Physiol Chem 349: 489–494PubMedGoogle Scholar
  441. 436.
    Wieland E (1994) Personal comminicationGoogle Scholar
  442. 437.
    Wieland H, Seidel D (1973) Improved techniques for assessment of serum lipoprotein patterns. II. Rapid method for diagnosis of type 3 hyperlipoproteinemia without ultracentrifugation. Clin Chem 19: 1139–1141Google Scholar
  443. 438.
    Wieland H, Seidel D, Wiegand V, Kreuzer H (1980) Serum lipoproteins and coronary artery disease (CAD). Comparison of the lipoprotein profile with the results of coronary angiography. Atherosclerosis 36: 269–280.PubMedGoogle Scholar
  444. 439.
    Wieland H, Seidel D (1983) A simple specific method for precipitation of low density lipoproteins. J Lipid Res 24: 904–909PubMedGoogle Scholar
  445. 440.
    Wiklund O, Dyer CA, Tsao BP, Curtiss LK (1985) Stoichiometric binding of apolipoprotein B-specific monoclonal antibodies to low density lipoproteins. J Biol Chem 260: 10956–10960PubMedGoogle Scholar
  446. 441.
    Williams KJ, Tall AR, Bisgaier C, Brocia R (1987) Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. J Clin Invest 79: 1466–1472Google Scholar
  447. 442.
    Williams KJ, Brocia RW, Fisher EA (1990) The unstirred water layer as a site of control of apolipoprotein B secretion. J Biol Chem 265: 16741–16744.PubMedGoogle Scholar
  448. 443.
    Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J (1992) Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 267: 26172–26180.PubMedGoogle Scholar
  449. 444.
    Wilson PW, Abbott RD, Castelli WP (1988) High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8: 737–741.PubMedGoogle Scholar
  450. 445.
    Windaus A (1910) Über den Gehalt normaler und atheromatöser Aorten und Cholesterin und Cholesterinestern. Hoppe Seylers Z Physiol Chem 67: 174–176Google Scholar
  451. 446.
    Windier E, Havel RJ (1985) Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceriderich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 26: 556–565Google Scholar
  452. 447.
    Wolf BB, Lopes MB, VandenBerg SR, Gonias SL (1992) Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 141: 37–42PubMedGoogle Scholar
  453. 448.
    Xu CF, Nanjee N, Tikkanen MJ, Huttunen JK, Pietionen P, Butler R, Angelico F, Del-Ben M, Mazzarella B, Antonio R, et al. (1989) Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levels. Hum Genet 82: 322–326PubMedGoogle Scholar
  454. 449.
    Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN (1981) Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10000 men. Lancet I: 1011–1015Google Scholar
  455. 450.
    Yamamura T, Yamamoto A, Sumiyoshi T, Hiramori K, Nishioeda Y, Nambu S (1984) New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type-III hyperlipoproteinemia. J Clin Invest 74: 1229–1237Google Scholar
  456. 451.
    Yano K, Reed DM, McGee DL (1984) Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemio 119: 653–666Google Scholar
  457. 452.
    Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086–1095PubMedGoogle Scholar
  458. 453.
    Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D (1991) Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87: 1146–1152PubMedGoogle Scholar
  459. 454.
    Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G (1986) Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 17: 942–945PubMedGoogle Scholar
  460. 455.
    Zampogna A, Luria MH, Manubens SJ, Luria MA (1980) Relationship between lipids and occlusive coronary artery disease. Arch Intern Med 140: 1067–1069PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • H. Wieland
  • W. März
  • M. Nauck

There are no affiliations available

Personalised recommendations